REG - Chrysalis Investment - Results of AGM

Chrysalis InvestmentsAnnouncement

Yesterday 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260331:nRSe9044Ya&default-theme=true

RNS Number : 9044Y  Chrysalis Investments Limited  31 March 2026

 

 

 

31 March 2026

 

Chrysalis Investments Limited

("Chrysalis" or the "Company")

 

Results of AGM

 

The Company announces the results of voting on the resolutions at its Annual
General Meeting ("AGM") held at 12:00 on Tuesday, 31 March 2026. All
resolutions were duly passed.

 

Andrew Haining, Chairman of Chrysalis commented: "The Board is firmly
committed to acting in the best interests of shareholders, and we thank them
for their continued support and confidence expressed at today's AGM. We remain
resolute in executing our investment policy, ensuring an orderly realisation
of assets and the efficient, timely return of capital. The Board will provide
a fuller update on Company operations and ongoing management arrangements in
our Quarterly NAV Announcement and Trading Update in early May."

 

 

 ORDINARY RESOLUTIONS                                                            FOR                 AGAINST            TOTAL VOTES  VOTES WITHHELD*
                                                                                 Votes        %      Votes       %
 To receive the Company's Financial Report and Audited Financial Statements for  288,914,813  99.73  776,029     0.27   289,697,042  1,090,953
 the period from 1 October 2024 to 30 September 2025

 To re-appoint KPMG Channel Islands Limited as auditor to the Company (the       289,547,571  99.61  1,136,283   0.39   290,690,054  97,941
 "Auditor") until the conclusion of the next general meeting at which accounts
 are laid before the Company

 To authorise the directors of the Company (the "Directors") to determine the    289,908,138  99.73  791,657     0.27   290,705,995  82,000
 remuneration of the Auditor

 ORDINARY RESOLUTIONS                                                            FOR                 AGAINST            FOR          AGAINST
                                                                                 Votes        %      Votes       %
 To approve the report of the Remuneration & Nomination Committee for the        289,604,918  99.67  952,473     0.33   290,563,591  224,404
 year ended 30 September 2025
 To re-elect Mr Andrew Haining as a Director of the Company who retires by       281,830,637  97.00  8,701,288   2.99   290,538,125  249,870
 rotation in accordance with Article 23.5 of the Articles

 To re-elect Mr Stephen Coe as a Director of the Company who retires by          287,609,670  99.00  2,913,015   1.00   290,528,885  259,110
 rotation in accordance with Article 23.5 of the Articles

 To re-elect Mr Tim Cruttenden as a Director of the Company who retires by       258,197,121  88.87  32,325,564  11.13  290,528,885  259,110
 rotation in accordance with Article 23.5 of the Articles

 To re-elect Mr Simon Holden as a Director of the Company who retires by         268,267,786  99.04  2,584,804   0.95   270,858,790  19,929,205
 rotation in accordance with Article 23.5 of the Articles

 To re-elect Ms Margaret O'Connor as a Director of the Company who retires by    259,845,064  89.44  30,677,621  10.56  290,528,885  259,110
 rotation in accordance with Article 23.5 of the Articles

 

 ORDINARY RESOLUTIONS                                                             FOR                 AGAINST          TOTAL VOTES  VOTES WITHHELD*
                                                                                  Votes        %      Votes      %
 To elect Mr Sam Dobyn as a Director of the Company who retires by rotation in    288,355,885  99.25  2,176,040  0.75  290,538,125  249,870
 accordance with Article 23.5 of the Articles

 To approve the Company's dividend policy and authorise the Directors to          286,810,898  98.69  3,792,514  1.31  290,609,612  178,383
 declare and pay all dividends of the Company as interim dividends

 SPECIAL RESOLUTIONS                                                              FOR                 AGAINST          TOTAL VOTES  VOTES WITHHELD*
                                                                                  Votes        %      Votes      %
 To authorise the Company, pursuant to Article 3.11 of the Articles, to allot     280,988,541  96.70  9,573,878  3.29  290,568,619  219,376
 and issue or make offers or agreements to allot and issue, grant rights to
 subscribe for, or to convert any securities into ordinary shares of no-par
 value

 To authorise the Company to make market acquisitions (as defined in the          289,795,045  99.72  805,741    0.28  290,606,986  181,009
 Companies (Guernsey) Law, 2008, as amended) of its own Ordinary Shares, either
 for cancellation or to hold as treasury shares for future resale or transfer

 

-ENDS-

 For further information, please contact

 Media

 Montfort Communications:                          +44 (0) 7921 881 800

 Charlotte McMullen / Imogen Saunders              chrysalis@montfort.london

 Investment Adviser                                +44 (0) 20 7871 5343

 Chrysalis Investment Partners LLP:

 James Simpson

 G10 Capital Limited (AIFM):                       +44 (0) 20 7397 5450
 Maria Baldwin

 Barclays Bank PLC:                                +44 (0) 20 7623 2323

 Dion Di Miceli / Stuart Muress / James Atkinson

 Panmure Liberum:                                  +44 (0) 20 3100 2222

 Chris Clarke / Darren Vickers

 Deutsche Numis:                                   +44 (0) 20 7260 1000

 Nathan Brown / Matt Goss

 IQEQ Fund Services (Guernsey) Limited:            +44 (0) 1481 231852

 Aimee Gontier / Elaine Smeja

 

LEI: 213800F9SQ753JQHSW24

 

A copy of this announcement will be available on the Company's website at
https://www.chrysalisinvestments.co.uk
(https://www.chrysalisinvestments.co.uk)

The information contained in this announcement regarding the Company's
investments has been provided by the relevant underlying portfolio company and
has not been independently verified by the Company. The information contained
herein is unaudited.

This announcement is for information purposes only and is not an offer to
invest. All investments are subject to risk. Past performance is no guarantee
of future returns. Prospective investors are advised to seek expert legal,
financial, tax and other professional advice before making any investment
decision. The value of investments may fluctuate. Results achieved in the past
are no guarantee of future results. Neither the content of the Company's
website, nor the content on any website accessible from hyperlinks on its
website for any other website, is incorporated into, or forms part of, this
announcement nor, unless previously published by means of a recognised
information service, should any such content be relied upon in reaching a
decision as to whether or not to acquire, continue to hold, or dispose of,
securities in the Company.

The Company is an alternative investment fund ("AIF") for the purposes of the
AIFM Directive and as such is required to have an investment manager who is
duly authorised to undertake the role of an alternative investment fund
manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ
Group). Chrysalis Investment Partners LLP (FRN: 1009684) is an Appointed
Representative of G10 Capital (FRN: 648953) Limited, which is authorised and
regulated by the Financial Conduct Authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGFLFFSVFILVIR



            Copyright 2019 Regulatory News Service, all rights reserved